Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice. 2015

Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China; College of Food Science and Engineering, Yangzhou University, Yangzhou 225127, China.

A water-soluble polysaccharide (MCP) was isolated from the fruits of Momordica charantia L., and the hypoglycemic effects of MCP were investigated in both normal healthy and alloxan-induced diabetic mice. MCP was orally administered once a day after 3 days of alloxan-induction at 100, 200 and 300mg/kg body weight for 28 day. Results showed that fasting blood glucose level (BGL) was significantly decreased, whereas the glucose tolerance was marked improvement in alloxan-induced diabetic mice, and loss in body weight was also prevented in diabetic mice compared to the diabetic control group. The dosage of 300mg/kg body weight exhibited the best effects. In addition, MCP did not exhibit any toxic symptoms in the limited toxicity evaluation in mice. The results suggest that MCP possess significantly dose-dependent anti-diabetic activity on alloxan-induced diabetic mice. Hence, MCP can be incorporated as a supplement in health-care food, drugs and/or combined with other hypoglycemic drugs.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D000496 Alloxan Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
March 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
November 2016, Molecular medicine reports,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
August 2018, International journal of biological macromolecules,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
October 2018, Gene,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
January 2012, Evidence-based complementary and alternative medicine : eCAM,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
March 1971, The West Indian medical journal,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
August 1987, Indian journal of experimental biology,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
April 2006, Journal of ethnopharmacology,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
February 2019, International journal of biological macromolecules,
Xin Xu, and Bin Shan, and Cai-Hu Liao, and Jian-Hua Xie, and Ping-Wei Wen, and Jia-Yi Shi
November 2006, Journal of ethnopharmacology,
Copied contents to your clipboard!